EPIDEMIOLOGY AND LONG-TERM CONSEQUENCES OF HEPATITIS DELTA VIRUS-INFECTION IN THE YUCPA INDIANS OF VENEZUELA

被引:31
|
作者
HADLER, SC
DEMONZON, MA
RIVERO, D
PEREZ, M
BRACHO, A
FIELDS, H
机构
[1] CTR DIS CONTROL,NATL CTR INFECT DIS,DIV VIRAL & RICKETTSIAL DIS,HEPATITIS BRANCH,ATLANTA,GA 30333
[2] CTR DIS CONTROL,NATL CTR PREVENT SERV,DIV IMMUNIZAT,ATLANTA,GA 30333
[3] DEPT PUBL HLTH,MARACAIBO,VENEZUELA
[4] MINIST HLTH,CARACAS,VENEZUELA
关键词
HEPATITIS-B VIRUS; HEPATITIS VIRUSES;
D O I
10.1093/oxfordjournals.aje.a116472
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To define better the epidemiology and clinical impact of hepatitis delta virus (HDV) infection among hepatitis B virus (HBV) carriers in less developed countries, the authors prospectively studied a cohort of 216 Yucpa Indian HBV carriers in Venezuela. HBV carriers were followed regularly between 1983 and 1988 by physical examination, laboratory testing for liver enzymes and HBV and HDV markers, and epidemiologic history. Among the cohort, 74 (34%) were initially positive for HDV infection, and 35 additional persons became infected during the study. Risk factors for new HDV infection included living in southern Yucpa villages; being young adults (15-19 years) or young children (1-9 years), and living in a household with a person with acute HDV infection. Persons with HDV infection were at high risk of developing chronic liver disease; 56% of HDV-infected persons had moderate-to-severe chronic liver disease at the end of the study compared with none of the HBV carriers without HDV infection. Mortality rates were 6.9% and 8.8% per year, respectively, among initially HDV-positive HBV carriers and those with new HDV infection, because of rapidly progressive chronic liver disease and fulminant hepatitis; mortality was significantly lower in HBV carriers without HDV infection and in non-HBV carriers. HDV superinfection is a devastating disease in HBV carriers in tropical South America. Prevention of HBV infection with hepatitis B vaccine is the best available tool to reduce the impact of this problem. Am J Epidemiol
引用
下载
收藏
页码:1507 / 1516
页数:10
相关论文
共 50 条
  • [31] EPIDEMIOLOGY OF HEPATITIS-E VIRUS-INFECTION IN TURKEY
    THOMAS, DL
    MAHLEY, RW
    BADUR, S
    PALAOGLU, KE
    QUINN, TC
    LANCET, 1993, 341 (8860): : 1561 - 1562
  • [32] SEROEPIDEMIOLOGY OF HEPATITIS DELTA VIRUS-INFECTION IN PUNE, INDIA
    ARANKALLE, VA
    RAMAMOORTHY, CL
    BANERJEE, K
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1992, 86 (01) : 89 - 89
  • [33] LONG-TERM SEQUELAE OF COXSACKIE-B VIRUS-INFECTION
    SPITZ, SA
    JOURNAL OF THE ROYAL COLLEGE OF GENERAL PRACTITIONERS, 1985, 35 (272): : 152 - 152
  • [34] NONINFLUENZA RESPIRATORY VIRUS-INFECTION IN LONG-TERM CARE FACILITIES
    FALSEY, AR
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1991, 12 (10): : 602 - 608
  • [35] PREVALENCE OF HEPATITIS-DELTA (DELTA) VIRUS-INFECTION - A SEROEPIDEMIOLOGIC STUDY
    DECOCK, KM
    JONES, B
    GOVINDARAJAN, S
    REDEKER, AG
    WESTERN JOURNAL OF MEDICINE, 1988, 148 (03): : 307 - 309
  • [36] Long-term prognosis of hepatitis C virus infection
    Behrman, AJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (20): : 2592 - 2592
  • [37] PROSPECTS FOR CONTROL OF HEPATITIS-B VIRUS-INFECTION - IMPLICATIONS OF CHILDHOOD VACCINATION AND LONG-TERM PROTECTION
    STEVENS, CE
    TOY, PT
    TAYLOR, PE
    LEE, T
    YIP, HY
    PEDIATRICS, 1992, 90 (01) : 170 - 173
  • [38] LONG-TERM EFFICACY OF ACTIVE POSTEXPOSURE IMMUNIZATION OF INFANTS FOR PREVENTION OF HEPATITIS-B VIRUS-INFECTION
    XU, ZY
    DUAN, SC
    MARGOLIS, HS
    PURCELL, RH
    OUYANG, PY
    COLEMAN, PJ
    ZHUANG, YL
    XU, HF
    QIAN, SG
    ZHU, QR
    WAN, CY
    LIU, CB
    GUN, ZL
    HUANG, CH
    ZHANG, ZJ
    REN, SL
    FRANCIS, DP
    MAYNARD, JE
    GERIN, JL
    HADLER, SC
    FIELDS, HA
    JOHNSON, L
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01): : 54 - 60
  • [40] EFFICACY OF GANCICLOVIR IN THE TREATMENT OF HEPATITIS-B VIRUS-INFECTION OF THE LIVER GRAFT - LONG-TERM RESULTS
    DELAMATA, M
    MONTERO, JL
    FRAGA, E
    COSTAN, G
    DELGADO, M
    LOPEZ, P
    GONZALEZ, R
    PERA, C
    MINO, G
    SOFIA, HR
    HEPATOLOGY, 1995, 22 (04) : 95 - 95